Navigation Links
SEDIPLAST ESR SYSTEM (with diluent)

ProductsSEDIPLAST ESR SYSTEM (with diluent)
Company Polymedco Inc.
Item SEDIPLAST ESR SYSTEM (with diluent)
Features 
  • Exclusive safety closure system
  • Automatic self-zeroing cap and reservoir
  • Pre-filled diluent & low sample volume
  • Pre-filled diluent & low sample volume
    • Description Unlike other ESR products, SEDIPLAST® is a completely closed system with superior design features to protect laboratory personnel from the risk associated with blood handling. SEDIPLAST® is a uniquely designed erythrocyte sedimentation rate test (Westergren) which provides greater safety and convenience as well as reliable and reproducible test results.
    Info Polymedco Inc.
    Customer Service: (800) 431-2123
    Web site: http://www.polymedco.com/

    Related medicine products :

    1. SEDIPLAST ESR SYSTEM (without diluent)
    2. DUALSWITCH-SHUNTSYSTEM for L-P-Derivation
    3. ISYSTEM-ABDv2™A/B Scan unit
    4. ISYSTEM-ABD A/B-scan unit
    5. ISYSTEM-ABDv2A/B Scan unit
    6. The REFLEXION 1st MPJ IMPLANT SYSTEM
    7. MEASLES (Rubeola) IgG ELISA TEST SYSTEM
    8. MUMPS IgG ELISA TEST SYSTEM
    9. VARICELLA-ZOSTER (VZ) IgG IFA TEST SYSTEM
    10. SYSTEM ONE Orbital Illumination System
    11. ALEXI® WOUND RETRACTOR SYSTEM
    Breaking Medicine Technology:Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Obesity While Young Boosts Pancreatic Cancer Risk 49819 1Obesity While Young Boosts Pancreatic Cancer Risk 49819 2Obesity While Young Boosts Pancreatic Cancer Risk 49819 3Lifeclinic Teams Up With Trucking Industry to Promote Health and Wellness to Over the Road Professionals 49815 1Lifeclinic Teams Up With Trucking Industry to Promote Health and Wellness to Over the Road Professionals 49815 2Lifeclinic Teams Up With Trucking Industry to Promote Health and Wellness to Over the Road Professionals 49815 321st Century Obesity Pandemic Still Suffering From Effects of Tuberculosis Plague of the 1800s 49811 121st Century Obesity Pandemic Still Suffering From Effects of Tuberculosis Plague of the 1800s 49811 221st Century Obesity Pandemic Still Suffering From Effects of Tuberculosis Plague of the 1800s 49811 321st Century Obesity Pandemic Still Suffering From Effects of Tuberculosis Plague of the 1800s 49811 4